Outsourced Pharma Capacity Update | July 2023

07.20.2023

Kevin Yarnall, Sr. Manager, Manufacturing, presented Emergent's manufacturing capabilities and available capacity at its Rockville, Maryland drug product facility during the Outsourced Pharma Capacity Webinar in June. If you missed the live presentation, watch ondemand to learn how Emergent is equipped to support the scale-up and CGMP manufacturing for your next clinical or commercial therapy.

OPCU Webinar - JUN2023 - Cover Image

Emergent CDMO

Drug Product Fill/Finish Webinars

06.28.2023

4 Steps for a Smooth Tech Transfer When Working with a CDMO

In our recent article with BioPharma Dive, Emergent's Shelly Buhay, Director of MS&T and Dan Perrin, Director of Manufacturing...

03.23.2020

Vaxart + Emergent: In the news

Original news coverage of Vaxart's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...

07.06.2020

Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate

Emergent will provide contract development and manufacturing services beginning in 2021 to produce drug substance at large...